A Sensitive Amphotericin B Immunoassay for Pharmacokinetic and Distribution Studies
Authors:
- 1 March 2000
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 44 (3) , 546-550
Abstract
Since currently used assays of amphotericin B (AMB) lack sensitivity or are not easily adaptable in all laboratories, we have developed an enzyme immunoassay for AMB in biological fluids and tissues. Antibodies to AMB were raised in rabbits after administration of an AMB-bovine serum albumin conjugate. The enzymatic tracer was obtained by coupling AMB via its amino group to acetylcholinesterase (EC 3.1.1.7 ). These reagents were used for the development of a competitive immunoassay performed on microtitration plates. The limit of quantification was 100 pg/ml in plasma and 1 ng/g in tissues. The plasma assay was performed directly without extraction on a minimal volume of 0.1 ml. The intra- and interassay coefficients of variation were in the range of 5 to 17%, and the recoveries were 92 to 111% for AMB added to human plasma. The assay was applied to a pharmacokinetic study with mice given AMB intraperitoneally at the dose of 1 mg/kg. The drug distribution in selected compartments (plasma, liver, spleen, lung, and brain) was monitored until 72 h after administration. In conclusion, our assay is at least 100-fold more sensitive than previously described bioassays or chromatographic determinations of AMB and may be useful in studying the tissue pharmacokinetics of new AMB formulations and in drug monitoring in clinical situations.Keywords
This publication has 25 references indexed in Scilit:
- Are we making progress in antifungal therapy?Current Opinion in Oncology, 1997
- Probing the dynamics of prion diseases with amphotericin BTrends in Microbiology, 1997
- Amphotericin B: new life for an old drugTrends in Pharmacological Sciences, 1996
- Rapid high performance liquid chromatographic assay for antifungal agents in human seraJournal of Antimicrobial Chemotherapy, 1996
- Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicansJournal of Antimicrobial Chemotherapy, 1995
- Activity of Liposomal Amphotericin B (AmBisome) AgainstLeishmania infantumand Tissue Distribution in MiceJournal of Drug Targeting, 1993
- Liposomal and Lipid Formulations of Amphotericin BClinical Pharmacokinetics, 1992
- Relationship of pharmacokinetics and drug distribution in tissue to increased safety of amphotericin B colloidal dispersion in dogsAntimicrobial Agents and Chemotherapy, 1992
- An Enzyme Immunoassay for Rat Prolactin: Application to the Determination of Plasma LevelsJournal of Immunoassay, 1991
- Induction of amphotericin B-specific antibodies for use in immunoassaysAntimicrobial Agents and Chemotherapy, 1984